In breast cancer cells, it was shown that miR-708-5p not only targeted CD276, an immune checkpoint molecule, but also decreased phosphorylated signal transducer and activator of transcription 3 (pSTAT3) levels [111]. The gene discussed is CD276; the disease is breast carcinoma.